ODF2L and colorectal carcinoma: We identified that rs4288473 C allele of ODF2L had poor progression‐free survival (PFS) and overall survival (OS) of CRC patients in the additive model (adjusted HRPFS = 1.39, 95% CI = 1.14–1.70, p = 1.36 × 10−3, and adjusted HROS = 1.31, 95% CI = 1.03–1.65, p = 2.62 × 10−2).